Caris Life Sciences · 19 hours ago
Vice President, Diagnostic Partnering
United States
Full-time
Remote
Director/Executive
$260K/yr - $300K/yr
12+ years expCaris Life Sciences is transforming cancer care through precision medicine and cutting-edge molecular science. They are seeking a strategic Diagnostic executive to lead biopharma partnerships and diagnostic strategy across oncology, ensuring collaborations deliver strategic and financial value while improving patient outcomes.
Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife Science
Responsibilities
Establish and own the long-term diagnostic strategy for biopharma collaborations, aligned with corporate growth objectives, oncology focus areas, and platform capabilities
Serve as a Dx subject matter expert for priority, top-tier pharma programs, providing authoritative input on biomarker strategy, assay selection, regulatory pathways, and development risk
Partner closely with the BBD lead on marquee strategic accounts, jointly shaping overall deal strategy, partner positioning, and long-term value creation
Independently originate, structure, and lead diagnostic partnerships for select pharma and biotech accounts, acting as the primary Partnering lead from initial engagement through execution
Lead CDx and advanced Dx co-development discussions, including biomarker selection, IUO/bridging approach, regulatory strategy, development timelines, and commercialization support
Serve as the strategic thought partner to executives and R&D leadership at biopharma companies, fostering trust and scientific alignment
Serve as the lead on cross-functional teams managing Dx partnerships from early-stage evaluation through prospective testing followed by regulatory submission, approval and market launch
Manage program timelines, deliverables, budgets, and risk mitigation strategies to ensure successful execution of partnership goals
Define partnership value propositions by integrating our scientific strengths with the commercial needs of biopharma customers
Represent the company as a senior external leader at major partnering forums and oncology conferences (e.g., JPM, BIO, ASCO, World CDx)
Shape diagnostic value propositions that integrate scientific differentiation, regulatory readiness, and commercial impact working with Dx product strategy team
Identify and pursue strategic opportunities diagnostic programs
Serve as the BD lead managing diagnostic partnerships from early-stage evaluation through deal closing
Define partnership value propositions by integrating our scientific strengths with the commercial needs of biopharma customers
Partner with Dx product strategy, marketing and competitive intelligence to craft differentiated messaging for Dx solutions
Ensure learnings from priority biopharma programs are reflected in broader Dx portfolio positioning and external narratives
Help strengthen external materials that clearly communicate the value of our Dx offerings to Biopharma and beyond
Lead and influence senior cross-functional leaders across R&D, clinical development, regulatory, quality, product, and commercial teams
Ensure diagnostic strategies are fully integrated into the broader oncology portfolio, platform roadmap, and corporate narrative
Build, mentor, and develop senior leaders and teams responsible for alliance management, Dx strategy, and execution
Qualification
Required
MS or PhD in molecular biology, genomics, oncology, or related field
12+ years of experience in the molecular diagnostics, biopharma, or precision medicine sectors, with a clear focus on diagnostics and oncology, with leadership responsibility
Demonstrated executive-level experience leading diagnostic, CDx, or biomarker-driven partnerships with/within biopharma
Track record of originating, structuring, closing or executing complex biopharma collaborations and strategic transactions
Deep understanding of oncology drug development, biomarker strategy, and global regulatory pathways for diagnostics
Experience operating as the senior external representative of an organization with biopharma partners
Strong executive presence with exceptional communication, negotiation, and strategic leadership skills
Preferred
PhD, MBA or equivalent commercial experience strongly preferred
Prior responsibility for Dx or CDx strategy
Deep understanding of NGS technologies (panel-based, whole exome/genome, RNAseq) and their clinical application in oncology
Experience with both LDT and IVD business models in a partner-driven context
Familiarity with clinical trial design, biomarker assay development, and the evolving landscape of personalized medicine
Benefits
Highly competitive and inclusive medical, dental and vision coverage options
Health Savings Account for medical expenses and dependent care expenses
Flexible Spending Account to pay for certain out-of-pocket expenses
Paid time off, including: vacation, sick time and holidays
401k match and Financial Planning tools
LTD and STD insurance coverages, as well as voluntary benefit options
Employee Assistance Program
Pet Insurance
Legal Assistance
Tuition Assistance
Company
Caris Life Sciences
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.86BKey Investors
BraidwellOrbiMedSixth Street
2025-06-18IPO
2025-04-07Private Equity· $168M
2023-01-19Debt Financing· $400M
Leadership Team
Luke Power
Chief Financial Officer
Brian Stengle
SVP, Chief Marketing Officer
Recent News
Labiotech UG
2026-01-17
2026-01-14
Company data provided by crunchbase